Relugolix–estradiol–norethisterone for treating symptoms of endometriosis

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 7.55 MB)

  Published:

  16 April 2025

• Final draft guidance committee papers (PDF 3.02 MB)

  Published:

  16 April 2025